Health-Related Quality of Life in Axillary Node-Negative, Estrogen Receptor-Negative Breast Cancer Patients Undergoing AC Versus CMF Chemotherapy: Findings from the National Surgical Adjuvant Breast and Bowel Project B-23

This publication has 12 references indexed in Scilit:

• Tamoxifen and Chemotherapy for Axillary Node-Negative, Estrogen Receptor–Negative Breast Cancer: Findings From National Surgical Adjuvant Breast and Bowel Project B-23
  Journal of Clinical Oncology, 2001
• Long-term quality of life in premenopausal women with node-negative localized breast cancer treated with or without adjuvant chemotherapy
  British Journal of Cancer, 2000
• Reliability and validity of the Functional Assessment of Cancer Therapy-Breast quality-of-life instrument.
  Journal of Clinical Oncology, 1997
• Impact of adjuvant therapy on quality of life in women with node-positive operable breast cancer
  The Lancet, 1996
• Base-Line Quality-of-Life Assessment in the National Surgical Adjuvant Breast and Bowel Project Breast Cancer Prevention Trial
  JNCI Journal of the National Cancer Institute, 1995
• The Functional Assessment of Cancer Therapy scale: development and validation of the general measure.
  Journal of Clinical Oncology, 1993
• Two months of doxorubicin-cyclophosphamide with and without interval reinduction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in positive-node breast cancer patients with tamoxifen-nonresponsive tumors: results from the National Surgical Adjuvant Breast and Bowel Project B-15.
  Journal of Clinical Oncology, 1990
• Quality of Life End Points in Cancer Clinical Trials: Review and Recommendations
  JNCI Journal of the National Cancer Institute, 1989
• A Test of Missing Completely at Random for Multivariate Data with Missing Values
  Journal of the American Statistical Association, 1988
• Estimating the Dimension of a Model
  The Annals of Statistics, 1978